Anavex Life Sciences Corp.
AVXL | NASDAQ
$2.46
+$0.06 (+2.50%)
Sep 22, 2026, 10:39 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.34M | -5.68M | -9.83M | -13.24M | -11.2M | -12.11M | -11.62M | -12.21M | -10.55M | -8.62M | -10.15M | -11.28M | -13.11M | -12.97M | -14.29M | -12.37M | -10.44M | -10.88M | -11.72M | -10.18M | -8.16M | -7.86M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | 1.11M | 3.72M | 4.32M | 1.45M | 2.06M | 2.01M | 2.49M | 2.65M | 2.29M | 3.19M | 3.87M | 3.97M | 5.35M | 6.04M | 3.99M | 4.44M | 3.91M | 3.15M | 2.29M | 1.85M | 939.31K |
Other Working Capital | n/a | -932K | -18K | -5.4M | 1.83M | 3.1M | -2.45M | 2.71M | -2.96M | -112K | 1.48M | -682K | -547K | 1.27M | 138.93K | 921.08K | -541.4K | -187.05K | 864.19K | 1.12M | 301.4K | 544.95K |
Other Non-Cash Items | 5.34M | n/a | n/a | n/a | n/a | n/a | 59K | -59K | n/a | n/a | 500 | n/a | 845K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.58M | -2.5M | -3.55M | 3.89M | -2.06M | 2.89M | 4.61M | -3.76M | -982K | 1.11M | -239K | -197K | 1.83M | 4.2M | 1.33M | -3.64M | 3.47M | 891.69K | 365.27K | -1.01M | -955.63K |
Operating Cash Flow | n/a | -7.15M | -8.6M | -12.46M | -5.86M | -12.12M | -6.66M | -5.18M | -11.66M | -7.32M | -5.85M | -7.65M | -8.49M | -5.79M | -4.04M | -7.05M | -9.64M | -3.5M | -7.67M | -7.52M | -7.32M | -7.87M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -445K | -2.26M | n/a | n/a | n/a | 444K | n/a | n/a | 868.34K | 469K | 181.5K | n/a | -75 | 327.91K | -251.3K | 226.78K | 2.22M | -2.06M | 127.57K | -263.46K |
Financial Cash Flow | n/a | 36.32M | 10.02M | -2.14M | 852K | 708K | 89K | 4.55M | 7.28M | 59K | 2.06M | 9M | 18.33M | 258K | 2.44K | 6.91M | 11.84M | 2.54M | 2.22M | 89.22M | 35.82M | 25.98M |
Net Cash Flow | -131.75M | 29.17M | 1.41M | -14.61M | -5M | -11.41M | -6.57M | -630K | -4.38M | -7.26M | -3.79M | 1.35M | 9.85M | -5.54M | -4.04M | -143.2K | 2.2M | -961.39K | -5.45M | 81.7M | 28.5M | 18.11M |
Free Cash Flow | n/a | -7.15M | -8.6M | -12.46M | -5.86M | -12.12M | -6.66M | -5.18M | -11.66M | -7.32M | -5.85M | -7.65M | -8.49M | -5.79M | -4.04M | -7.05M | -9.64M | -3.5M | -7.67M | -7.52M | -7.32M | -7.87M |
Adj. Free Cash Flow | n/a | -8.26M | -12.33M | -16.79M | -7.31M | -14.18M | -8.67M | -7.67M | -14.31M | -9.6M | -9.04M | -11.52M | -12.46M | -11.14M | -10.09M | -11.04M | -14.08M | -7.41M | -10.83M | -9.81M | -9.16M | -8.81M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | n/a | -7.15M | -8.6M | -12.46M | -5.86M | -12.12M | -6.66M | -5.18M | -11.66M | -7.32M | -5.85M | -7.65M | -8.49M | -5.79M | -4.04M | -7.05M | -9.64M | -3.5M | -7.67M | -7.52M | -7.32M | -7.87M |
Add to Watchlist
Select watchlists to add or remove AVXL